Two Complementary Injections

ChondroFiller® and Arthrosamid®

Both are clinic-delivered, ultrasound-guided injections, and they target different parts of the joint. ChondroFiller® coats the cartilage at the load-bearing bone surfaces; Arthrosamid® integrates into the synovial lining. Because they address different anatomical structures, they can be used together as a staged plan when assessment supports both. Where both are indicated, they are usually given at separate appointments; in selected cases they may be given in the same session, with the order and timing based on patient needs. Here is what each does on its own and how they are used together.

Illustration of ChondroFiller injected under ultrasound guidance to coat the worn cartilage surface of the knee
  1. Collagen scaffold
  2. Ultrasound-guided injection
  3. Coats the worn surface

ChondroFiller®

A collagen scaffold injected under ultrasound guidance. It sets in minutes and coats the worn cartilage so your own cells can lay down new tissue.

Illustration of Arthrosamid injected into the knee joint, where it integrates with the joint lining
  1. Hydrogel injection
  2. Integrates with the joint lining

Arthrosamid®

A non-absorbable hydrogel injected into the knee that integrates with the joint lining to help ease osteoarthritis symptoms.

Quick answer

ChondroFiller® and Arthrosamid® work on different parts of the same joint, and they have different intended roles. ChondroFiller® coats the cartilage at the load-bearing bone surfaces and supports natural cartilage restoration over six to twelve months (£3,000 to £8,000 depending on box quantity). Arthrosamid® is a hydrogel that integrates into the synovial lining and calms it from the inside. Its observational cohort reports group outcomes through 24 months, not a guaranteed duration, and current treatment starts at £3,000. A combined plan is built from a clinical rationale for each component, and the injections are usually given at separate appointments.

How it works

ChondroFiller® vs Arthrosamid®: the key difference

ChondroFiller® is a collagen scaffold delivered onto the cartilage at the load-bearing bone surfaces, where it coats and restores the cartilage layer; the body’s own cells then migrate in and lay down new matrix over six to twelve months. Arthrosamid® is a polyacrylamide hydrogel that integrates into the synovial lining of the joint, where it settles an inflamed lining and loosens a stiff capsule; it is not regenerative. The two treatments target two anatomically distinct parts of the same joint, which is why they complement each other: one restores the cartilage surface, the other works on the lining. If both are indicated, they are usually given at separate appointments, and in selected cases in the same session.

How each treatment works

ChondroFiller®

Ultrasound-guided knee injection, with the probe held on the knee while the needle is placed
Delivered as a single ultrasound-guided injection in clinic, the same way as Arthrosamid®.

ChondroFiller® is a sterile type I collagen scaffold injected as a liquid into the joint under ultrasound guidance. Within minutes it sets in place and coats the cartilage layer at the load-bearing bone surfaces, restoring the surface across the joint in a single delivery.

The patient’s own cells then migrate into the scaffold and lay down new cartilage matrix over the following six to twelve months. ChondroFiller® coats, protects and supports natural cartilage restoration; it does not act on the joint lining.

Arthrosamid®

Close-up of an ultrasound probe on a knee while a needle is guided into the joint
A single ultrasound-guided injection into the joint cavity, in clinic.

Arthrosamid® is a 2.5% polyacrylamide hydrogel injected into the joint cavity under ultrasound guidance. Over the following weeks the synovial membrane grows into the gel and it becomes a permanent part of the joint lining.

It is the lining that changes: a stiff, irritated capsule becomes more settled and more supple. Nothing is left between the joint surfaces, so it is not a lubricant and not a cushion for the cartilage. It does not regenerate cartilage, does not reverse arthritis and does not alter the joint surface.

Looking ahead

What can you expect over time?

ChondroFiller®

Tissue formation over 6–12 months

The scaffold sets in minutes, but new cartilage tissue forms over six to twelve months as cells migrate in. Published cohorts show maintained outcomes (IKDC, Harris Hip Score, MOCART MRI) at five years and beyond in suitable focal defects.

Arthrosamid®

Outcomes reported through 24 months

A prospective observational cohort reports group-level outcomes through 24 months. It had no randomised control group, so this follow-up period is a group result; individual response and duration vary.

Read the comparison in context

Direct duration comparison is misleading. ChondroFiller® coats and restores the cartilage surface across the joint; Arthrosamid® controls symptoms by calming the synovial lining. We measure their success differently.
Explore the ChondroFiller evidence →

Your treatment plan

Number of injections

ChondroFiller®

Typically one injection course, with the box quantity (one, two or three) decided from MRI: one box treats most defects up to roughly 2 cm², two or three for larger or multi-zone defects. A second course is rarely needed if the original tissue establishes.

Arthrosamid®

One injection is the standard treatment course in suitable patients. A further Arthrosamid® treatment may be considered at a future date if symptoms recur and the joint is still suitable.

Ultrasound-guided knee injection at London Cartilage Clinic, with the probe on the knee and the needle entering under sterile drapes
Both products are delivered under ultrasound guidance in a sterile field at 66 Harley Street, as outpatient appointments.

The treatment journeys

ChondroFiller® pathway

  1. 1

    Consultation and MRI review

    Professor Lee reviews your MRI and examination to confirm suitability and how many boxes of ChondroFiller® are needed.
  2. 2

    Ultrasound-guided injection

    A 30 to 45 minute outpatient appointment under local anaesthetic, with the scaffold setting in place within minutes.
  3. 3

    Home the same hour

    No brace or crutches unless your medical team specifies otherwise, then a free telephone review at six weeks.

Arthrosamid® pathway

  1. 1

    One ultrasound-guided injection

    The 2.5% polyacrylamide hydrogel is injected into the joint cavity, with one injection the standard course in suitable patients.
  2. 2

    The lining takes up the gel

    Over the following weeks the synovial membrane grows into the gel and it becomes a permanent part of the joint lining.
  3. 3

    Six-week follow-up

    The follow-up is included in the price, and a further treatment may be considered later if symptoms recur and the joint is still suitable.

Care and precautions

Understanding the risks

BEFORE · DURING · AFTER

Sterile technique.
Image guidance.
Clear aftercare.

Both are outpatient injections and both carry risks, including joint infection. London Cartilage Clinic uses ultrasound guidance, a sterile field and its documented antibiotic protocol. These precautions reduce avoidable risk but cannot eliminate infection or guarantee placement or outcome.

ChondroFiller® placement is defect-specific, so ultrasound guidance is not optional: it is the difference between filling the defect and depositing scaffold into the joint space. See Arthrosamid® infection risk and prevention for the injection-specific protocol that applies to both products.

Practical planning and safety

Questions to raise before either option

Ask about temporary soreness or swelling, the risk of joint infection, and anything specific to your health and current medicines. Ask who you contact if something does not feel right afterwards.

Who may suit ChondroFiller →

Aftercare depends on the route

After the ChondroFiller injection there is no brace and no crutches unless your medical team specifies otherwise. Keyhole surgery follows the manufacturer's rehabilitation, with a brace for 48 hours and weight rebuilt over about six to eight weeks.

Read the injection aftercare guide →

Your joint, your goals

Where does each option fit?

Illustration of a knee joint at three stages of cartilage wear, from healthy to thinning to exposed bone
Cartilage wear is a spectrum. The pattern on MRI, not the stage alone, decides which structure needs treating.

ChondroFiller® coats the load-bearing cartilage surface of the joint, whether the wear is a contained focal defect or diffuse across the surface. There is no upper age limit and no defect-size limit on the injection. It is delivered to the cartilage at the ends of the bones, the part of the joint where bone meets bone under load. See who is suitable for ChondroFiller?.

Arthrosamid® is for patients with established knee osteoarthritis who want long-lasting symptom relief without surgery, where an inflamed synovial lining is driving a meaningful part of the pain. See who is suitable for Arthrosamid?

Many patients have a reason to consider both products: cartilage wear at the bone surfaces and an irritated joint lining. Each has its own indication and consent, and the injections are usually given at separate appointments, or in selected cases in one session, with the order and timing set as part of the treatment plan. Imaging, history and examination together shape that plan.

What would make the difference for you?

Questions worth taking to your consultation, so the discussion stays on your joint.

  1. 01What is causing my joint pain?The diagnosis and your imaging decide which treatments are worth discussing.
  2. 02Is there a defect, or wear across the joint?Ask how the pattern of cartilage damage shapes the recommendation.
  3. 03What improvement are we aiming for?Agree realistic goals for pain, function and timescale before you choose.
  4. 04What happens if I need more help later?Ask which options stay open if symptoms return or progress.
Arrange a discovery call

Planning the cost

Compare the complete care package

Ultrasound-guided injection

ChondroFiller®

From · one box

£3,000

Two boxes £5,500; three boxes £8,000. The consultation is charged separately.

Full ChondroFiller pricing →

Arthrosamid®

Arthrosamid®

From

£3,000

One box, inclusive of ultrasound, the product, the fifteen-step injection protocol and the six-week follow-up. The consultation (£350) is charged separately.
Arthrosamid® cost guide →

At London Cartilage Clinic, ChondroFiller® costs from £3,000 for one box, £5,500 for two and £8,000 for three. The box requirement is set from MRI, not by upsell. See the ChondroFiller® cost guide.

Arthrosamid® at London Cartilage Clinic is from £3,000 for one box, inclusive of ultrasound, the product, the fifteen-step injection protocol and the six-week follow-up, with the consultation (£350) charged separately. See the Arthrosamid® cost guide.

Both prices cover the named clinician, named injection and named follow-up, with the consultation charged separately. The right comparison is clinical fit, not headline number.

Published London Cartilage Clinic prices. Your clinical assessment confirms the appropriate treatment and plan.

Two ChondroFiller liquid boxes, 1.0 ml and 2.3 ml, from meidrix
ChondroFiller®: one injection course. The number of boxes is set from your MRI, not by upsell.
Arthrosamid pre-filled 1 ml syringes laid out in front of their orange boxes
Arthrosamid®: one injection, priced all-in with ultrasound, the product and the six-week follow-up. Consultation charged separately.

Making a recommendation

When each option may make sense

ChondroFiller®

A discussion to have

  • You have cartilage wear visible on MRI, whether a contained focal defect or diffuse across the joint surface.
  • You want a treatment that coats and protects the cartilage at the load-bearing bone surfaces, with no upper age limit and no defect-size limit.
  • You want a meaningful intervention before, or instead of, considering joint replacement, including as part of a staged plan with Arthrosamid® where the synovial lining is also driving symptoms. ChondroFiller and Arthrosamid are usually given at separate appointments.

Arthrosamid®

A discussion to have

  • You have established knee osteoarthritis with whole-joint symptoms.
  • You want long-lasting symptom relief from a hydrogel that integrates into the synovial lining, with realistic expectations of what an injection can and cannot do.
  • You want to consider non-surgical symptom management while accepting that Arthrosamid has not been proved to delay knee replacement.

When both are indicated

How a staged plan works

When MRI and examination show wear at the cartilage surface and a lining that is driving symptoms, the two injections are usually planned as separate appointments so each product can settle into its own structure. In selected cases both are given in the same session.

  1. 1

    Consultation and MRI review

    Professor Lee reviews your scans, history and examination, and confirms which structures need treating and in what order.
  2. 2

    First injection

    An ultrasound-guided outpatient visit at 66 Harley Street. Most patients walk out the same hour.
  3. 3

    The interval

    Where the injections are given at separate appointments, the gap is set as part of your plan, with the first product left to establish before the second is placed.
  4. 4

    Second injection

    The other product is delivered to its own target, again under ultrasound guidance.
  5. 5

    Follow-up

    Review at six weeks, with onward physiotherapy available if it will help your recovery.
Knee joint cross-section showing ChondroFiller coating the cartilage surfaces and Arthrosamid lining the inside of the joint capsule
Both in place after a staged plan: ChondroFiller® on the cartilage surfaces, Arthrosamid® along the synovial lining.

Choosing another path

When another approach may be better

ChondroFiller®

A reason to reconsider

  • A single contained focal defect in an otherwise healthy joint with strong biological capacity for regeneration, where the Liquid Cartilage™ surgical regeneration pathway may be a more targeted intervention.
  • Untreated joint instability or major malalignment, where the mechanical problem needs to be addressed first.
  • Active infection or unwillingness to accept the conservative safety protocol.

Arthrosamid®

A reason to reconsider

  • A patient looking for cartilage restoration: Arthrosamid® works on the synovial lining, not the cartilage at the bone surfaces. ChondroFiller® is the right answer for that, and a plan may include both where each has a separate rationale. They are usually given at separate appointments, and in selected cases in the same session.
  • End-stage disease where joint replacement is the clinically appropriate path.
  • Patients expecting Arthrosamid® to regenerate cartilage; that is not what the treatment does.

The bottom line

ChondroFiller® and Arthrosamid® are both ultrasound-guided clinic injections, but they work on different parts of the joint. ChondroFiller® coats the cartilage at the load-bearing bone surfaces; Arthrosamid® integrates into the synovial lining. Because they treat two different structures, a staged plan can use both. When both are indicated, the injections are usually given at separate appointments, and in selected cases in the same session, depending on patient needs. Where the pattern of damage points to one alone, we recommend just that one. Where a surgical pathway is a better fit, we say so honestly, and the Liquid Cartilage™ pathway is one of the options we will discuss.

Common questions

01

Can I have both ChondroFiller® and Arthrosamid® in the same session?

Usually they are given at separate appointments. In selected cases, where clinically indicated and based on your needs, both may be given in the same session. This is decided at consultation. The two treatments target different parts of the joint: ChondroFiller® coats the cartilage at the load-bearing bone surfaces, while Arthrosamid® integrates into the synovial lining, so staging usually lets each settle into its own structure. Each has its own rationale and consent, and imaging and examination set the order and timing.

02

Which one regenerates cartilage?

ChondroFiller® supports natural cartilage regeneration by providing a scaffold for the body’s cells to lay down new matrix over six to twelve months. Arthrosamid® does not regenerate cartilage; it is a hydrogel taken up by the synovial membrane, and its target is the lining, not the cartilage.

03

Which has more clinical evidence?

Both have published cohort data. The London Cartilage Clinic/MSK Doctors Arthrosamid® cohort included 269 patients and 314 knees with 24-month follow-up, but no randomised control group. ChondroFiller® has cartilage-specific outcome data (IKDC, Harris Hip Score, MOCART MRI) and over 19,000 cases of clinical use across joints. See the ChondroFiller® clinical evidence page.

04

Why is ChondroFiller® priced by boxes when Arthrosamid® is a flat fee?

A ChondroFiller® scaffold has to fill the defect; box quantity is set by defect size on MRI (one, two or three). Arthrosamid® is dosed by joint, not by defect size, so a single box covers the standard knee injection.

05

I have arthritis with one bad spot, which is right for me?

That is a consultation question, and the answer is often one of them, sometimes both. ChondroFiller® addresses cartilage wear at the bone surfaces, including a focal bad spot and any wider surface wear. Arthrosamid® is intended for symptomatic adult knee osteoarthritis and, if also indicated, is usually given at a separate appointment. We review the MRI, history and examination and recommend only the component or pathway with a defensible rationale.

06

Is one safer than the other?

A simple claim that they have the same safety profile would be misleading. Both are outpatient injections and both carry infection and procedure-related risks; Arthrosamid is non-absorbable and has product-specific contraindications and antibiotic requirements. London Cartilage Clinic uses ultrasound, a sterile field and its documented antibiotic protocol, without claiming these eliminate risk.

Book a ChondroFiller® Assessment in London

Natural cartilage regeneration starts with the right defect, the right operator, and the right plan. Start with a free call, or book a consultation with Professor Lee at our Harley Street clinic.
Privacy & Cookies PolicyTerms & ConditionsFeedback & Complaints
Free Discovery Call